/Companies

SRT Therapeutics

San Diego, US · Founded 2024 · Delaware corporation

Find your way into SRT Therapeutics

Sign up to see every warm intro you have to SRT Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the SRT Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

LOLauren Otsuki
Lauren OtsukiExecutive

Board

RB
Rolf BenirschkeBoard director
BG
Brian G. Feagan, M.D.Board director
EP
Ed PrunchunasBoard director
MW
Michael WalshBoard director
SW
Shierley WidjajaBoard director

Reported raises · per SEC filings

Form D private placements

$47.4M disclosed across 1 round · 2025

▶$47.4MraisedAug 2025 · 55 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rolf BenirschkeDirector
  • Brian G. Feagan, M.D.Director
  • Ed PrunchunasDirector
  • Michael WalshDirector
  • Lauren OtsukiExecutive Officer, Director
  • Shierley WidjajaDirector
Offering amount
$47.5M
Amount sold
$47.4M
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has SRT Therapeutics raised?
SRT Therapeutics has disclosed $47.4M raised across 1 round.
Where is SRT Therapeutics headquartered?
SRT Therapeutics is headquartered in San Diego, US.